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Neutrophils are important in controlling early infections with the intracellular bacterium Rhodococcus equi.
Antineutrophil monoclonal antibody (RB6-8C5)-induced neutrophil deficiency during the first week after
experimental infection of mice with R. equi resulted in more severe disease and significantly increased tissue
concentrations of R. equi.
Rhodococcus equi is an opportunistic facultative-intracellu-
lar bacterium that causes severe disease, principally pneumo-
nia, in immunocompromised people (e.g., AIDS patients and
organ transplant recipients) and in very young horses (foals)
(13). It survives and replicates in macrophages and shares
many phenotypic, phylogenetic, and pathogenic characteristics
with Mycobacterium species (13).
Specific host factors that determine the outcome of exposure
to R. equi have not been identified; however, evidence indi-
cates that innate immune responses are important in the con-
trol of early infections (4, 7, 9, 10) and that cell-mediated
immunity, via T-helper 1 (Th1) immune responses, is impor-
tant in resistance to infection (2).
Neutrophils provide protection against a variety of intracel-
lular organisms by both phagocytic and nonphagocytic mech-
anisms (1, 3, 5, 7, 10–12, 14). They phagocytize and kill many
pathogens, including R. equi (7, 10), and produce an array of
cytokines and chemokines that modulate immune responses to
infection by directing the recruitment and activation of other
effector cells. Such actions influence the development of T-cell
responses that favor a Th1-type response. Neutrophils, there-
fore, are considered to be important in linking innate and
acquired immune functions.
Neutrophil responses and disease control contributions,
however, are not the same for all intracellular bacterial infec-
tions, suggesting that microorganism and perhaps host factors
may be important determinants. For instance, early infections
with fast-replicating intracellular bacteria (e.g., Salmonella en-
terica serovar Typhimurium) are controlled by neutrophils (3,
14), whereas infections with slow-replicating Mycobacterium
tuberculosis organisms are not adequately controlled because
of the neutrophils’ inconsistent or lack of ability to kill the
bacteria (14). Neutrophils do, however, appear to have a
nonphagocytic immunomodulatory protective role against
early systemic M. tuberculosis infections (12). The protective
role of neutrophils in the pathogenesis of infection with M.
tuberculosis, however, is unclear: following M. tuberculosis in-
fection of mice genetically susceptible to pulmonary tubercu-
losis, neutrophil degranulation contributes to lung tissue de-
struction over time, rather than to microbe destruction (6). To
our knowledge, there are no published reports on the in vivo
effects of neutrophils on R. equi-induced disease.
The purpose of this study was to determine the importance
of neutrophils in the control of early R. equi infections in mice.
Herein we present evidence that mice deficient in neutrophils
are more susceptible to experimental infection with R. equi and
develop substantially greater bacterial burdens than do neu-
trophil-replete mice.
Female BALB/c mice (Harlan Laboratories, Indianapolis,
IN), 7 to 9 weeks of age, were segregated based on their
treatment with an antineutrophil monoclonal antibody (MAb;
RB6-8C5) (principal mice; n  10) or normal mouse serum-
(control mice; n  8). This study was approved by the Texas
A&M University Animal Care and Use Committee. Principal
mice received 200 g of RB6-8C5 (obtained from T.A.M.)
intraperitoneally (i.p.), in a 0.5-ml volume, and control mice
received 0.5 ml of normal mouse serum (Sigma Chemical Co.,
St. Louis, MO) i.p (11). Treatments were administered 18 h
before R. equi infection and at 1 and 4 days postinfection (p.i.)
in those that survived.
Virulent R. equi (ATCC 33701) bacteria were grown in R.
equi minimal medium (8) for 48 h at 37°C with rotation (10
rpm), centrifuged at 1,600  g for 10 min, resuspended in
phosphate-buffered saline (PBS), and stored at 80°C until
used. Bacterial suspensions were thawed at 37°C prior to in-
fection, and R. equi concentrations were assessed by duplicate
plate counts on Trypticase soy agar with 10% sheep red blood
cells (Beckton-Dickinson Microbiology Systems, Cockeysville,
MD) and reported in CFU/ml. All mice were injected i.p. with
0.2 ml of bacterial suspension, containing approximately 3 
105 R. equi bacteria (15).
At 7 days p.i., mice were anesthetized with methoxyflurane
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(Pitman-Moore, Mundelein, IL) and euthanized by cardiac
snip, and blood was collected for hemograms. Livers, spleens,
and lungs were aseptically harvested, weighed, and homoge-
nized in sterile PBS using tissue grinders (Wheaton, Millville,
N.J.). Aliquots (100 l) of 10-fold serial PBS-homogenate di-
lutions were cultured, in duplicate, on plates containing Tryp-
ticase soy agar and 10% sheep red blood cells to quantify the
number of CFU of R. equi per gram of tissue. Lung, liver, and
spleen tissues from representative mice in each group, princi-
pal (n  4) and control (n  2), were collected at 7 days p.i.
and examined histologically.
Continuous data were non-Gaussian in distribution and
were compared using the Wilcoxon rank-sum test. Compari-
sons of categorical data were made using the Fisher exact test.
P values of 0.05 were considered significant.
Three principal mice appeared ill (i.e., ruffled fur, lethargy,
and hunched stature) 24 h p.i., did not receive a second dose of
MAb, and died at 36 to 48 h p.i. Although the proportion of
principal mice that died (30%; 3 of 10) was greater than that of
control mice (0%), the difference was not significant.
At 7 days p.i., the remaining principal mice exhibited early
signs of disease (i.e., slightly ruffled fur and moderately re-
duced activity), whereas all control mice were normal in ap-
pearance and activity. Concurrently, principal mice had signif-
icantly (P  0.0015) lower concentrations of peripheral blood
neutrophils (median, 44 neutrophils/l; range, 0 to 174 neu-
trophils/l) than control mice (median, 480 neutrophils/l;
range, 156 to 1,144 neutrophils/l). The finding of a significant
neutropenia 3 days after administration of RB6-8C5 MAb is
consistent with previous observations (11, 12, 14).
There were no apparent gross lesions in the organs of any
surviving mice, but the spleens of principal mice were larger
and significantly (P 0.0015) heavier (median weight, 251 mg;
range, 215 to 315 mg) than those of control mice (median
weight, 82 mg; range, 55 to 94 mg). The livers of surviving
principal mice were significantly (P  0.0489) heavier (median
weight, 1,026 mg; range, 909 to1,134 mg) than those of control
mice (median weight, 894 mg; range 853 to 1,118 mg).
In comparison to the findings for control mice, histologic
examination of tissues from principal mice that survived 7 days
p.i. revealed (i) severe peritonitis, characterized by mononu-
clear inflammation; (ii) intense splenic extramedullary myelo-
poiesis with occasional granulomas containing bacteria; and
(iii) increased hepatic myeloid extramedullary myelopoiesis
(Fig. 1). The lungs of both groups exhibited similar degrees of
mild acute interstitial pneumonia. The splenic and hepatic
myeloid hyperplasia correlated with the increased organ
weights and most likely represented the host’s responses to
RB6-8C5-induced neutrophil destruction, peritoneal neutro-
phil sequestration, and ongoing systemic disease. The perito-
nitis in principal mice may also explain their increased severity
of clinical signs.
FIG. 1. Tissue responses representative of those seen in principal (neutrophil-deficient) and control (neutrophil-replete) mice at 7 days p.i. with
R. equi. (A and B) Note islands of myeloid hyperplasia (arrows) scattered in liver sinusoids from a principal mouse (A), compared to the absence
of myeloid hyperplasia in liver tissue from a control mouse (B). Hematoxylin and eosin stain; magnification, 10. (C) In the principal mouse,
mononuclear peritonitis (arrow) and increased areas of splenic myeloid hyperplasia, characterized by a proliferating neutrophilic population having
bean-shaped to circularized linear nuclei and expanding the parenchyma below the capsule (arrowheads), are evident. (D) In the control mouse,
there is no evidence of peritonitis, and the spleen parenchyma below the capsule (arrowheads) is normal. Hematoxylin and eosin stain;
magnification, 20.
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There were significantly (P 0.0014) greater concentrations
of R. equi in the livers of principal mice (median, 7,720 CFU/g;
range 2,630 to 121,000 CFU/g) than in control mice (median,
234 CFU/g; range, 0 to 568 CFU/g) and significantly (P 
0.0015) greater concentrations of R. equi in the spleens of
principal mice (median, 18,100 CFU/g; range, 5,240 to 242,000
CFU/g) than in control mice (median, 891 CFU/g; range 0 to
2,670 CFU/g). Although not significant (P 0.067), there were
more R. equi organisms in the lungs of surviving principal mice
(median, 692 CFU/g; range, 0 to 51,000 CFU/g) than in control
mice (median, 29 CFU/g; range 0 to 5,150 CFU/g) (Fig. 2).
A laboratory animal model of R. equi pneumonia is lacking,
and the virulence status of R. equi isolates has been established
by infecting mice either intravenously or i.p. and quantifying
the concentrations of bacteria in their spleens, livers, and lungs
(15). The finding of relatively lower concentrations of organ-
isms in the lungs than in the spleens or livers is consistent with
the results of previous experimental systemic infections of mice
with R. equi (15). The finding of similar patterns of pneumonia
in principal and control mice correlated well with the observed
similarities in tissue concentrations of R. equi, thereby provid-
ing further evidence that the lung is not the primary target
organ in mice infected systemically with R. equi. On the basis of
increased tissue burdens of R. equi in neutrophil-deficient mice
in this study and the in vitro R. equi-killing capacity of neutro-
phils in previous studies (7, 10), it is quite likely that a neutro-
phil deficiency or inefficiency would contribute to increased
lung bacterial burdens and lesions in animals predisposed to R.
equi pneumonia (i.e., young foals).
During primary infection with most intracellular bacteria,
the host must rely on innate defenses to prevent organisms
from growing to overwhelming numbers before specific adap-
tive immunity can be generated and expressed. This is the first
report on the importance of neutrophils in disease caused by R.
equi, and the results indicate that they substantially reduce
tissue bacterial burdens in mice. Additional studies are needed
to determine the mechanistic basis of this protective response
and the means by which it might be enhanced.
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FIG. 2. Neutrophils protect against infection with R. equi. Bacterial
burdens in the liver, spleen, and lung 7 days after R. equi infection of
principal mice rendered neutropenic with RB-8C5 MAb (E) and neu-
trophil-replete control mice (). Individual CFU values and the me-
dian (horizontal line) values for all surviving principal (n  7) and
control (n  8) mice are shown. Wilcoxin rank-sum analyses indicated
a significant difference (P  0.05) in median concentrations of R. equi
in livers and spleens, between principal and control mice, but not a
significant difference in these concentrations in their lungs.
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